Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-02-09

Clinical Trial Update: BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases [Phase 2, Phase 3]

View source ↗

Summary

A pediatric trial evaluating BSEP function rescue in hereditary cholestatic diseases has been withdrawn after Phase 2/3 participation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Hereditary Diseases, Cholestasis, Intrahepatic | Phase 2, Phase 3 | Status: WITHDRAWN